SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2962002 - [Memantine AD Trail][End Date 10/31/2003] - A Randomized, Double-Blind, John McCarthy-2/3/2002
2952002 - [Yahoo Test][Phase 2 - AD ][Version 2] =================================John McCarthy-2/3/2002
2942002 - [Yahoo Test][Phase 2 - AD ][Version 1] =================================John McCarthy-2/3/2002
2932002 - [Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagoJohn McCarthy-2/3/2002
2922002 - [Excitatory glycine receptors containing the NR3 family of NMDA receptor John McCarthy-2/3/2002
2912001 - [Separation methods for tricyclic antiviral drugs. ] 1: J Chromatogr B BJohn McCarthy-2/3/2002
2902002 - [Terrific Phenserine presentation by Axonyx] Axonyx Business Strategy ..John McCarthy-2/3/2002
2892002 - [A nice NEOT story][mentions Memantine and FRX March filing] Bring Back John McCarthy-2/3/2002
2882002 - [Mild Cognitive Impairment][Seems to suggest that the problem is TOO MUCHJohn McCarthy-2/3/2002
2872002 - [A possible NEGATIVE comment about Lundbeck or Memantine or both][Hard toJohn McCarthy-2/3/2002
2862001 - [Regional Drug and Therapeutics Center - UK][New Drug Treatments and theiJohn McCarthy-2/3/2002
2852002 - [1.7 million USA Aricept users] ARICEPT(R) (donepezil hydrochloride tablJohn McCarthy-2/3/2002
2842002 - [AD Trial Location - Seattle] University of Washington Health Sciences RJohn McCarthy-2/3/2002
2832002 - [AD Trial Location Regions Hospital] Research Study: You can help! RegiJohn McCarthy-2/3/2002
2822002 - [AD Trial Location - California - San Fran] A Study of an InvestigationaJohn McCarthy-2/3/2002
2812002 - [Hawaii][MEMANTINE SHOWS POSITIVE TEST RESULTS] Memantine is an N-methylJohn McCarthy-2/3/2002
2802002 - [German Article][Memantine mentioned][Medicines are evalutated differentlJohn McCarthy-2/3/2002
2792002 - [Memantine sold by Table/Injection/Drop] look for Akatinol/Memantine tJohn McCarthy-2/3/2002
2782002 - [1/18/2002 - German Article about Memantine] Medicine innovation A medJohn McCarthy-2/3/2002
2772002 - [Institute's research points to 'excited' brain activity][LipJohn McCarthy-2/3/2002
2762001 - Tardive dyskinesia (TD) affects approximately 15-20% of patients treatJohn McCarthy-2/3/2002
2752001 - [Yahoo Test][Phase 3 - Alzheimers - Version 5] =========================John McCarthy-1/27/2002
2742001 - [Yahoo Test][Phase 3 - Alzheimers - Version 4] =========================John McCarthy-1/27/2002
2732001 - [Yahoo test][Phase 3 - Alzheimers - Version 3] =========================John McCarthy-1/26/2002
2722001 - [Yahoo Test][AD - Phase3 - Second Test Version] ========================John McCarthy-1/26/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News